On Tuesday, the market did not witness a follow-up buying after a strong rebound of bulls from the lows of Monday.

In fact, in the last two trading sessions, the sector gained nearly 4 per cent while on an MTD basis, it delivered an eye-popping return of 13.21 per cent and has been the show-stopper.

In Q4FY22, the financial performance of the pharma companies was affected by the rising raw material & freight costs. Despite the pressure on margins, some pharmaceutical companies managed to showcase decent financial performance in Q4FY22. 

BSE Sensex tanked over 600 points while Nifty 50 is weak by almost 200 points on Tuesday. BSE Midcap index is down by more than a per cent in line with the key benchmark indices while BSE Small cap index plunged 0.70 per cent.  

BSE Sensex has tumbled approximately 7 per cent in 2022, so far. In CY2021, BSE Sensex was up by nearly 22 per cent. Several stocks more than doubled in 2021 thus, helping to create wealth for investors.

On Thursday, the benchmark indices opened flat, tracking mixed global cues. At 11.40 am, Sensex was trading lower by 297 points or 0.55 per cent while Nifty plunged 110 points or 0.69 per cent. Speciality chemicals company- Aether Industries' initial public offering (IPO) had been subscribed 56 per cent by the morning of May 26, the third and final day of booking.  

Markets are falling, with the Nifty 50's weekly returns becoming negative. In this post, we will look at stocks that have outperformed the Nifty 50 on a weekly basis.

On Friday, the markets opened on a weaker note with Sensex slipping beyond 500 points and Nifty declining over 160 points on the back of weak global cues.  

The equity markets addressed the year 2022 with vitality. The high spirits persisted for a week or so, post which, the markets exhibited a turbulent performance. In the past three months, the benchmark indices dropped up to 12 per cent thereby, rebounding up to 11.58 per cent till today as the geopolitical tensions between Russia and Ukraine were majorly controlling the performance of the markets.    

The equity markets are still under cautious view due to the uncertainty of the Russia-Ukraine crisis along with the oil prices on the boil. Although the economy has shown positive momentum based on earnings growth, deleveraging, and rising Capex announcement along with a robust government budget, the volatility is still likely to persist due to the hawkish US Federal Reserve as well as the recent crisis between Russia and Ukraine.